Quality of life for women after transposition of urethra
Heading: Urology and andrology Article type: Original article
Authors: Komyakov В.К., Shevnin M.V., Ochelenko V.A., Tarasov V.A.
Organization: City Multidisciplinary Hospital №2, Mariinsky Hospital, North-West State Medical University n.a. I.I. Mechnikov, Department of Neuropathology Assistant Professor, Candidate of Medical Science, Urology Center with Robot-assisted Surgery
Objective: to evaluate the quality of life, sexual function in women with recurrent postcoital cystitis before and after urethral transposition. Material and methods. The study included women suffering from recurrent postcoital cystitis, who underwent transposition of urethra by Komyakov in the period from 2019-2021. Quality of life was assessed using the SF-12v2 questionnaire. Sexual function was assessed using the Female Sexual Function Index (FSFI). Atotal of 60 patients were included in the study, who filled out questionnaires before and after surgery. The average age was 28.8 ±5.2 years. Results. Quality of life indicators for all domains were statistically significantly different in the pre- and postoperative period. Changes in the indicator of the physical component of the quality of life according to the questionnaire before the operation were 50.6±8.4 points, after the operation 57±3.7 (p<0.001). More pronounced differences were noted in the mental component of the quality of life, the total score before surgery was 35.4± 10.4, and after surgery the total score was 47.5±5.6 (p<0.001). An analysis of the sexual function showed a pronounced difference both between each domain of the FSFI questionnaire and the total score before (21.49±3.67) and after the intervention (29.9±2.7), p<0.001. Conclusion. In patients with recurrent postcoital cystitis, there is a decrease in the quality of life and sexual function. After transposition of urethra, there is an improvement the quality of life and the sexual life of patients.
Bibliography:
1. Perepanova TS. Uncomplicated urinary tract infection. In: Lopatkin NA, Perepanova TS, eds. Rational pharmacothera-py in urology: Guide for practitioners. Moscow: Litterra, 2012, p. 303-18.
2. Foxman В. The epidemiology of urinary tract infection. Nat Rev Urol 2010; (7): 653-60.
3. Komyakov BK. Extravaginal transposing of the urethra in the treatment of postcoital cystitis. Urologiia 2013; (5): 12-5.
4. Ernst EJ, Ernst ME, Hoehns JD, et al. Women's quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment. Health Qual Life Outcomes 2005; (3): 45.
5. Wagenlehner F, Wullt B, Ballarini S, et al. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Rev Pharma-coecon Outcomes Res 2018; 18 (1): 107-17.
6. Abrahamian FM, Krishnadasan A, Mower WR, et al. The association of antimicrobial resistance with cure and quality of life among women with acute uncomplicated cystitis. Infection 2011; (39): 507-14.
7. Salonia A, Clementi MC, Graziottin A, et al. Secondary provoked vestibulodynia in sexually active women with uncomplicated recurrent urinary tract infections. J Sex Med 2013; 10 (9): 2265-73.
8. Boeri L, Capogrosso P, Ventimiglia E, et al. Six out of ten women with recurrent urinary tract infections complain of distressful sexual dysfunction — A case-control study. Sci Rep 2017; (7): 44380.
9. Komyakov BK, Tarasov VA, Ochelenko VA, et al. Patho-genesis and treatment of postcoital cystitis: are our approaches correct? Urologiia 2022; (2); 27-32.
10. Ware JE, Kosinski М, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; (34): 220-33.
11. Wiegel M, Meston C, Rosen R. The Female Sexual Function Index (FSFI): Cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005; (31): 1-20.
12. Ellis AK, Verma S. Quality of life in women with urinary tract infections: is benign disease a misnomer? J Am Board Fam Pract2000; 13 (6): 392-7.
Attachment | Size |
---|---|
2022_3_350-353.pdf | 430.59 KB |